ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,359.41
0.56%
Dow Jones
44,705.53
-0.17%
Gold vs US Dollar
2,645.925
0.12%
Brent Oil
73.745
0.19%
Bitcoin
95,863.46
-0.11%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Faron Pharmaceuticals Oy (FARN)

  7. Faron Pharmaceuticals Oy (FARN) News

Faron Pharmaceuticals Oy (FARN)

Faron Pharmaceuticals Oy
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:FARN
DateTimeSourceHeadlineSymbolCompany
02/12/202408:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Interactions with UK Regulatory AuthoritiesLSE:FARNFaron Pharmaceuticals Oy
27/11/202411:29Alliance NewsAlliance NewsFaron announces promising findings from blood cancer drug trialLSE:FARNFaron Pharmaceuticals Oy
27/11/202407:00RNS Regulatory NewsFaron Pharmaceuticals Oy Positive Phase 2 Interim Results from BEXMAB TrialLSE:FARNFaron Pharmaceuticals Oy
11/11/202407:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Targeting Soluble Clever-1 for Autoimmune DiseasesLSE:FARNFaron Pharmaceuticals Oy
05/11/202407:00RNS Regulatory NewsFaron Pharmaceuticals Oy Shareholders’ Nomination BoardLSE:FARNFaron Pharmaceuticals Oy
22/10/202406:00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron’s Capital Markets Day 2024LSE:FARNFaron Pharmaceuticals Oy
07/10/202406:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Faron announces Capital Markets DayLSE:FARNFaron Pharmaceuticals Oy
30/08/202406:00RNS Regulatory NewsFaron Pharmaceuticals Oy Grant of optionsLSE:FARNFaron Pharmaceuticals Oy
27/08/202410:08Alliance NewsAlliance NewsFaron Pharma shares surge as US FDA grants fast track designationLSE:FARNFaron Pharmaceuticals Oy
27/08/202406:00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron 2024 Half-Year Financial ResultsLSE:FARNFaron Pharmaceuticals Oy
27/08/202406:00RNS Regulatory NewsFaron Pharmaceuticals Oy FDA Grants Fast Track Designation for BexmarilimabLSE:FARNFaron Pharmaceuticals Oy
20/08/202406:00RNS Regulatory NewsFaron Pharmaceuticals Oy Notice of Half-Year Financial ResultsLSE:FARNFaron Pharmaceuticals Oy
13/08/202412:23Alliance NewsAlliance NewsIN BRIEF: Faron Pharmaceuticals joins US grant for battlefield woundsLSE:FARNFaron Pharmaceuticals Oy
13/08/202406:00RNS Non-RegulatoryFaron Pharmaceuticals Oy Traumakine Research Collaboration and DoD GrantLSE:FARNFaron Pharmaceuticals Oy
12/08/202411:01Alliance NewsAlliance NewsEXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRxLSE:FARNFaron Pharmaceuticals Oy
08/08/202406:00RNS Regulatory NewsFaron Pharmaceuticals Oy Appointment of Chief Financial OfficerLSE:FARNFaron Pharmaceuticals Oy
07/08/202409:00RNS Regulatory NewsFaron Pharmaceuticals Oy Grant of optionsLSE:FARNFaron Pharmaceuticals Oy
06/08/202415:51Alliance NewsAlliance NewsIN BRIEF: Faron Pharmaceuticals names Petri Bono as CMOLSE:FARNFaron Pharmaceuticals Oy
06/08/202407:30RNS Regulatory NewsFaron Pharmaceuticals Oy Faron Appoints Dr. Petri Bono as new CMOLSE:FARNFaron Pharmaceuticals Oy
11/07/202418:23Alliance NewsAlliance NewsTRADING UPDATES: Titon warns on trading; Videndum revenue in-lineLSE:FARNFaron Pharmaceuticals Oy
11/07/202406:00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron Announces Positive FDA FeedbackLSE:FARNFaron Pharmaceuticals Oy
25/06/202413:00RNS Regulatory NewsFaron Pharmaceuticals Oy Update on settlementLSE:FARNFaron Pharmaceuticals Oy
25/06/202409:30RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in Company - ReplacementLSE:FARNFaron Pharmaceuticals Oy
24/06/202411:45RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
24/06/202411:45RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
24/06/202411:45RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
24/06/202411:45RNS Regulatory NewsFaron Pharmaceuticals Oy Holding(s) in CompanyLSE:FARNFaron Pharmaceuticals Oy
20/06/202412:00RNS Regulatory NewsFaron Pharmaceuticals Oy New shares registered with Finnish Trade RegisterLSE:FARNFaron Pharmaceuticals Oy
20/06/202406:00RNS Regulatory NewsFaron Pharmaceuticals Oy Fully subscribed EUR 30.7 million share offeringLSE:FARNFaron Pharmaceuticals Oy
05/06/202407:00RNS Regulatory NewsFaron Pharmaceuticals Oy Proposed REX Retail OfferLSE:FARNFaron Pharmaceuticals Oy
 Showing the most relevant articles for your search:LSE:FARN

Your Recent History

LSE
GGP
Greatland Gold
LSE
PANR
Pantheon Resources
LSE
BARC
Barclays
LSE
PRIM
Primorus Investments
LSE
AAZ
Anglo Asian Mining
LSE
KOS
Kosmos Energy
LSE
IES
Invinity Energy Systems
LSE
CHAR
Chariot
LSE
QBT
Quantum Blockchain Techn...
LSE
BOO
Boohoo
LSE
EDEN
Eden Research
LSE
STX
Shield Therapeutics
LSE
LIT
Litigation Capital Manag...
LSE
EMVC
Emv Capital
LSE
SRB
Serabi Gold
LSE
SCLP
Scancell
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved